COPD

The gut-lung axis behind COPD

There's a genuinely strong evidence trail behind the gut's role in COPD, or chronic obstructive pulmonary disease, a lung condition that makes breathing progressively harder over time. COPD is the third leading cause of death worldwide. The connection is not just observed from a distance either, it has been tested directly in a randomised clinical trial. A 2025 meta-analysis pooled 21 studies on the topic. Together, they covered 1,273 people with COPD and 6,718 healthy people. The pattern held consistently: people with COPD had a less diverse, disrupted gut microbiome, a state researchers call dysbiosis, compared with people without the disease. Researchers call this two-way relationship between gut and lungs the gut-lung axis.

Source: Frontiers in Cellular and Infection Microbiology, Gut microbiome dysbiosis in chronic lung disease: a systematic review and meta-analysis

What happens when the gut is actively supported

A meta-analysis of randomised controlled trials found that probiotic supplementation raised FEV1, a standard measure of how much air a person can force out of their lungs in one second, by around 3 percentage points in people with stable COPD. That finding came from two trials covering 160 patients in total, both testing a multi-strain probiotic blend taken alongside standard COPD treatment over several weeks. The same review also looked at COPD animal studies. There, probiotics reduced inflammatory markers including TNF-α and IL-6. They also raised the anti-inflammatory marker IL-10 and reduced lung scarring. Those animal results have not yet been confirmed in human patients, but they point to a plausible reason the human lung function findings hold up.

It is worth remembering that a probiotic supplement only introduces new bacteria. It does not guarantee they will thrive once they arrive. Think of it like restocking a zoo. Bringing in new animals does not help if the zoo is not feeding them properly. They will simply die back out. A probiotic works alongside fibre and plant compounds that keep the new arrivals fed, rather than acting as a stand-alone fix.

Separate population data points the same direction. A US study used survey data from more than 7,400 adults to test this. People who regularly consumed probiotics, prebiotics, or yoghurt had a 25% lower prevalence of COPD than people who did not, even after accounting for age, smoking status, and other health conditions. That does not prove cause and effect on its own, but it is a second, independent line of evidence pointing the same way as the trial data above.

Source: PMC, Effects of probiotic treatment on patients and animals with chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized control trials

Source: PMC, The potential protective effects of probiotics, prebiotics, or yogurt on chronic obstructive pulmonary disease: Results from NHANES 2007-2012

COPD and the gut show up together elsewhere too

A nationwide South Korean study tracked more than 1.3 million people with COPD and 6.5 million people without it. COPD patients developed inflammatory bowel disease at a noticeably higher rate than people without COPD, 9.98 cases per 100,000 person-years compared with 7.18. Once other factors were accounted for, the overall risk of developing inflammatory bowel disease was 38% higher in the COPD group, and that risk rose further as COPD became more severe. A separate study profiled gut bacteria in 60 COPD patients of varying severity. It found the microbiome shifted as the disease progressed, with certain bacteria, including Fusobacterium, becoming more common in the most severe stages. A larger study went further, comparing gut bacteria in COPD patients against healthy people. It found 146 bacterial species that reliably differed between the two groups. Several of these, including two Streptococcus species and members of the Lachnospiraceae family, were directly linked to how well a person's lungs were functioning, not just to having COPD in general.

Source: PubMed, Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study

Source: PMC, Comprehensive profiling of the gut microbiota in COPD of varying severity

Source: Nature Communications, Disease-associated gut microbiome and metabolome changes in patients with COPD

What this means for you

COPD needs proper diagnosis and treatment from a doctor, including stopping smoking where relevant, inhalers, and regular monitoring of lung function through spirometry testing. Worsening breathlessness, blue-tinged lips, or a sudden flare in symptoms need urgent medical attention. The trial data on probiotics and lung function, backed by the population data above, is a genuine reason to also take gut-supportive habits seriously alongside that care. A wide variety of plant foods each week, plus fermented foods like yoghurt if well tolerated, feed the same bacteria this research repeatedly ties to calmer airway inflammation and better lung function. That's the same idea behind GutLab, everyday gut health starts with regularly feeding the microbiome a broad range of plant-rich ingredients.